REQUEST A DEMO
Total
USD $0.00
Search more companies

Dr.Max 198 S.R.O. (Slovakia)

Main Activities: Pharmacies and Drug Stores | Department Stores
Full name: Dr.Max 198 S.R.O. Profile Updated: October 21, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Dr.Max 198 S.R.O. is an enterprise in Slovakia, with the main office in Kosice. The company operates in the Pharmacies and Drug Stores industry. The company was established on March 26, 2020. In 2025, the company reported a net sales revenue increase of 55.77%. Its’ total assets recorded a growth of 27.14%. In, 2025, the company’s net profit margin increased by 0.87%.

Headquarters
Moldavska cesta, 8/A
Kosice; Kosicky; Postal Code: 04011

Contact Details: Purchase the Dr.Max 198 S.R.O. report to view the information.

Basic Information
Registered Capital:
Purchase the Dr.Max 198 S.R.O. report to view the information.
Financial Auditors:
Purchase the Dr.Max 198 S.R.O. report to view the information.
Incorporation Date:
March 26, 2020
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Dr.Max 198 S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
55.77%
Total Operating Revenue
55.53%
Operating Profit
104.82%
EBITDA
81.77%
Net Profit/Loss for the Period
145.17%
Total Assets
27.14%
Total Equity
103.4%
Operating Profit Margin
0.74%
Net Profit Margin
0.87%
Return on Equity (ROE)
8.67%
Debt / Equity
-0.11%
Quick Ratio
0.19%
Cash Ratio
0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?